Document Detail


SUNCT syndrome responsive to gabapentin (Neurontin).
MedLine Citation:
PMID:  11037748     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 48-year-old male suffering with SUNCT (severe unilateral neuralgiform headache with conjunctival injection and tearing, rhinorrhea and sub-clinical sweating) presented in 1996 after a 10-year history of multiple failed therapies. The symptoms included strictly left-sided ocular, as well as facial and temple pain. The pain attacks were burning, sharp, shooting and occurred 25 times daily, lasting 2 to 3 minutes with tearing and conjunctival injection. There was no associated nausea or vomiting, but there was photophobia. No other autonomic changes were reported and the pain was not triggerable. Initially Indocin (indomethacin) was tried without significant benefit. Gabapentin (Neurontin) was then started with improvement at 1800 mg per day. The patient was then lost to follow-up for 3 years, as he moved from the Los Angeles area. He returned in 1999 having stopped the gabapentin after his prescription ran out in 1996, reporting the pain returned immediately. Again gabapentin was prescribed and at 900 mg three times daily he has been pain free for 12 months.
Authors:
S B Graff-Radford
Related Documents :
8958538 - Local injection therapy in 107 patients with myofascial pain syndrome of the head and n...
16083458 - A narrative review of intra-articular corticosteroid injections for low back pain.
20420518 - Hyaluronidase: a review of approved formulations, indications and off-label use in chro...
16846958 - Pain following controlled cutaneous insertion of needles with different diameters.
22398138 - Knee kinetic pattern during gait and anterior knee pain before and after rehabilitation...
20566568 - Bariatric surgery and renal function: a precarious balance between benefit and harm.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cephalalgia : an international journal of headache     Volume:  20     ISSN:  0333-1024     ISO Abbreviation:  Cephalalgia     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2001-01-22     Completed Date:  2001-02-01     Revised Date:  2013-06-11    
Medline Journal Info:
Nlm Unique ID:  8200710     Medline TA:  Cephalalgia     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  515-7     Citation Subset:  IM    
Affiliation:
The Pain Center of Cedars-Sinai Medical Center and UCLA School of Dentistry, Los Angeles, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetates / therapeutic use*
Amines*
Analgesics / therapeutic use*
Conjunctival Diseases / drug therapy*
Cyclohexanecarboxylic Acids*
Headache / drug therapy*,  physiopathology
Humans
Lacrimal Apparatus Diseases / drug therapy*
Male
Middle Aged
Neuralgia / drug therapy*,  physiopathology
Nose Diseases / drug therapy*
Retreatment
Sweating / drug effects*
Syndrome
gamma-Aminobutyric Acid*
Chemical
Reg. No./Substance:
0/Acetates; 0/Amines; 0/Analgesics; 0/Cyclohexanecarboxylic Acids; 56-12-2/gamma-Aminobutyric Acid; 6CW7F3G59X/gabapentin
Comments/Corrections
Comment In:
Cephalalgia. 2002 Apr;22(3):249; author reply 249-50   [PMID:  12047467 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recurrent short-lasting headache associated with paroxysmal hypertension: a clonidine-responsive syn...
Next Document:  Enamelin maps to human chromosome 4q21 within the autosomal dominant amelogenesis imperfecta locus.